Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

The isoxazole derivative of usnic acid induces ER stress response in breast cancer cells that leads to paraptosis-like cell death

ABSTRACT: This work investigated the molecular mechanisms unterlying the previously reported anticancer activity of the usnic acid isoxazole derivative, named 2b. Using RNA-seq technology transcriptoms of MCF-7 breast cancer cells treated with vehicle or 2b for two diffrent time periods were compared. Among differentially expressed genes, components of the protein processing in endoplasmic reticulum pathway were the most significantly upregulated by 2b.

ORGANISM(S): Homo sapiens

PROVIDER: GSE191314 | GEO | 2021/12/23

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

The isoxazole derivative of usnic acid induces ER stress response in breast cancer cells that leads to paraptosis-like cell death

Project description:The isoxazole derivative of usnic acid induces ER stress response in breast cancer cells that leads to paraptosis-like cell death

| PRJNA790972 | ENA

Comparison of the prostate cancer cell line LNCaP and its androgen insensitive derivative C4-2B

2007-08-07 | GSE7702 | GEO

Comparison of the prostate cancer cell line LNCaP and its androgen insensitive derivative C4-2B

Project description:LNCaP and its androgen insensitive derivative were profiled in order to identify genes differentially expressed during the conversion to androgen insensitivity. This experiment was performed due to the presence of an ins(7;14) localizing the entire ETV1 locus to chr 14 in LNCaP and C4-2B prostate cancer cells. Keywords: cell type comparison LNCaP and C4-2B were both hybridized to Agilent Whole Human Genome Oligonucleotide Microarrays, with a commercially obtained pool of benign prostate RNA serving as the reference for both cell lines. Dye flips for both cell lines were also performed

2007-08-07 | E-GEOD-7702 | biostudies-arrayexpress

miRNA expression changes in HC-T116 cells before and after SHU00238 treatment

Project description:newly developed isoxazole derivative SHU00238 suppressed cell proliferation and promoted cell apoptosis in vitro， SHU00238 treatment significantly inhibited colonic tumor growth in vivo. we used microarrays to detail the miRNA expression in HCT116 cell line underlying the influence of SHU00238

2019-06-13 | GSE132619 | GEO

Gene expression analysis of enzalutamide resistant MDA PCa 2b prostate cancer cells

Project description:MDA PCa 2b is an androgen-responsive, AR-positive prostate cancer cell line. Here, we report the generation of an Enzalutamide-resistant derivative, MDA PCa 2b-EnzaR. Gene expression of MDA PCa 2b-EnzaR compared to its parental counterpart were assessed by short-read RNA sequencing.

2024-09-26 | GSE254612 | GEO

Effects of isoxazole (ISX) on long-term cultured human islets

Project description:Novel strategies are needed to modulate β-cell differentiation and function as potential β-cell replacement or restorative therapies for diabetes. We previously demonstrated that small molecules based on the isoxazole scaffold drive neuroendocrine phenotypes. The nature of the effects of isoxazole compounds on β cells was incompletely defined. We find that isoxazole largely induced genes that support neuroendocrine and β-cell phenotypes, and suppressed a set of genes important for proliferation. Isoxazole alters β-cell metabolites and protects glucose-responsive signaling pathways under lipotoxic conditions. Finally, we show that isoxazole improves glycemia in a mouse model of β-cell regeneration. Isoxazole is a prime candidate for altering cell fate in different contexts.

2017-08-22 | GSE74240 | GEO

Downregulation of chemokine (C-C motif) ligand 5 (CCL5) induced by a novel 8-hydroxyquinoline derivative (91b1) suppresses tumor invasiveness in esophageal carcinoma

Project description:Esophageal squamous cell carcinoma (ESCC) is a particularly aggressive form of cancer with high mortality. In this study, a novel 8-hydroxyquinoline derivative (91b1) was investigated for the anticancer activities in ESCC alongside the associated mechanisms. The in vitro cytotoxic effect of 91b1 were evaluated across five ESCC cell lines using MTS assay, with cisplatin serving as a comparative standard. Changes in gene expression profile were identified by cDNA microarray and further validated by qPCR and immunostaining. Additionally, protein levels of the most significantly downregulated target in archival ESCC samples was also studied. 91b1 demonstrated comparable anticancer effect with cisplatin. Notably, CCL5 was identified as the most substantially downregulated gene, with its suppression at both mRNA and protein expression in ESCC cells, exhibiting a dose-dependent manner. The recombinant human protein of CCL5 enhanced the invasion of ESCC cells using the trans-well assay. The upregulation of CCL5 protein was also detected in 50% of ESCC cell lines. CCL5 was also overexpressed in 76.9% of ESCC specimens. The overall results indicated that 91b1 could effectively induce anticancer effect on ESCC cells through downregulating CCL5 expression with suppression of tumor invasion. Overall, these findings suggest that 91b1 effectively inhibits ESCC cell proliferation and tumor invasion by downregulating CCL5 expression, highlighting its potential as a therapeutic agent for ESCC treatment. We used microarrays to identify the most regulated gene expression of KYSE 150 cells treated with compound 91b1.

2024-07-29 | GSE273055 | GEO

SCL008: icSARS CoV, icSARS-deltaNSP16 or icSARS ExoNI infections of the 2B4 clonal derivative of Calu-3 cells - Time course

Project description:Purpose of experiment was to compare transcriptomics of 2B4 cells (clonal derivative of Calu-3 cells) infected with either icSARS CoV, icSARS-deltaNSP16 or icSARS ExoNI mutants. 2B-4 cells (clonal derivatives of Calu-3 cells) were infected with either icSARS CoV, icSARS deltaNSP16 or icSARS ExoNI. Wild type and deltaNSP16 mutant infections were at an MOI of 5 while the ExoNI infections were at an MOI of 1. Cells samples were collected at 0, 7, 12, 24, 36, 36, 48, 60 or 72h post infection. Each infected sample was done in triplicate. (Triplicates are defined as 3 different wells, plated at the same time using the same cell stock for all replicates.) There are triplicate time-matched Mock for each time point from the same cell stock as rest of samples. Culture medium (the same as what the virus stock is in) was used for the Mock infections.

2014-05-23 | E-GEOD-48142 | biostudies-arrayexpress

Effect of benzimidazole derivative C162 on Staphylococcus aureus virulence

Project description:From a Caenorhabditis elegans - S. aureus anti-infective screen, we identified benzimidazole derivative C162 as one of the potential anti-infective candidate that rescued the infected-nematodes from infection. This compound was found to exhibit anti-biofilm activity against S. aureus. To investigate the transcriptome profile of S. aureus in response to benzimidazole derivative C162, a genome-wide transcriptome analysis was performed on C162-treated S. aureus using the Affymetrix GeneChip S. aureus Genome Arrays. Our main interest is to look at the expression profiles of the biofilm-associated and virulence genes.

2018-02-13 | GSE84485 | GEO

Trifolium repens cultivar:cv 'Crau'-derivative

Project description:Trifolium repens cultivar:cv 'Crau'-derivative Genome sequencing and assembly

| PRJNA523044 | ENA